HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 280, Issue 3, 1882-1892, January 21, 2005

This Article Full Text Full Text (PDF) Supplemental Data All Versions of this Article: 280/3/1882    most recent M409427200v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Laugel, B. Articles by Sewell, A. K. Search for Related Content PubMed PubMed Citation Articles by Laugel, B. Articles by Sewell, A. K. Social Bookmarking                      What's this?

Design of Soluble Recombinant T Cell Receptors for Antigen Targeting and T Cell Inhibition^*

Bruno Laugel, Jonathan M. Boulter, Nikolai Lissin¶, Annelise Vuidepot¶, Yi Li¶, Emma Gostick, Laura E. Crotty||, Daniel C. Douek||, Joris Hemelaar**, David A. Price||, Bent K. Jakobsen¶, and Andrew K. Sewell

From the The T-cell Modulation Group, The Peter Medawar Building for Pathogen Research, University of Oxford, South Parks Rd., Oxford OX1 3SY, United Kingdom, Department of Medical Biochemistry and Immunology, University of Wales College of Medicine, Heath Park, Cardiff CF14 4XN, United Kingdom, ^¶Avidex Ltd., 57 Milton Park, Abingdon, Oxon OX14 4RX, United Kingdom, ^||Human Immunology Section, Vaccine Research Center, NIAID, National Institutes of Health, Bethesda, Maryland 20892, and ^**Magdalen College, University of Oxford, Oxford OX1 4AU, United Kingdom

The use of recombinant T cell receptors (TCRs) to target therapeutic interventions has been hindered by the naturally low affinity of TCR interactions with peptide major histocompatibility complex ligands. Here, we use multimeric forms of soluble heterodimeric TCRs for specific detection of target cells pulsed with cognate peptide, discrimination of quantitative changes in antigen display at the cell surface, identification of virus-infected cells, inhibition of antigen-specific cytotoxic T lymphocyte activation, and identification of cross-reactive peptides. Notably, the A6 TCR specific for the immunodominant HLA A2-restricted human T cell leukemia virus type 1 Tax^11–19 epitope bound to HLA A2-HuD^87–95 (K_D 120 µM by surface plasmon resonance), an epitope implicated as a causal antigen in the paraneoplastic neurological degenerative disorder anti-Hu syndrome. A mutant A6 TCR that exhibited dramatically increased affinity for cognate antigen (K_D 2.5 nM) without enhanced cross-reactivity was generated; this TCR demonstrated potent biological activity even as a monomeric molecule. These data provide insights into TCR repertoire selection and delineate a framework for the selective modification of TCRs in vitro that could enable specific therapeutic intervention in vivo.

Received for publication, August 17, 2004 , and in revised form, November 1, 2004.

^* This work was funded by the Wellcome Trust. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The on-line version of this article (available at http://www.jbc.org) contains Supplemental Figs. 1–5.

A Medical Research Council Clinician Scientist.

A Wellcome Trust Senior Fellow. To whom correspondence should be addressed. Tel.: 44-1865-281539; Fax: 44-1865-281530; E-mail: andy.sewell{at}ndm.ox.ac.uk.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				Y. Balagurunathan, D. L. Morse, G. Hostetter, V. Shanmugam, P. Stafford, S. Shack, J. Pearson, M. Trissal, M. J. Demeure, D. D. Von Hoff, et al. Gene expression profiling-based identification of cell-surface targets for developing multimeric ligands in pancreatic cancer Mol. Cancer Ther., September 1, 2008; 7(9): 3071 - 3080. [Abstract] [Full Text] [PDF]

				B. D. Santomasso, W. K. Roberts, A. Thomas, T. Williams, N. E. Blachere, M. E. Dudley, A. N. Houghton, J. B. Posner, and R. B. Darnell A T cell receptor associated with naturally occurring human tumor immunity PNAS, November 27, 2007; 104(48): 19073 - 19078. [Abstract] [Full Text] [PDF]

				G.A. Loset, E. Lunde, B. Bogen, O.H. Brekke, and I. Sandlie Functional phage display of two murine {alpha}/{beta} T-cell receptors is strongly dependent on fusion format, mode and periplasmic folding assistance Protein Eng. Des. Sel., October 9, 2007; (2007) gzm044v1. [Abstract] [Full Text] [PDF]

				B. Laugel, H. A. van den Berg, E. Gostick, D. K. Cole, L. Wooldridge, J. Boulter, A. Milicic, D. A. Price, and A. K. Sewell Different T Cell Receptor Affinity Thresholds and CD8 Coreceptor Dependence Govern Cytotoxic T Lymphocyte Activation and Tetramer Binding Properties J. Biol. Chem., August 17, 2007; 282(33): 23799 - 23810. [Abstract] [Full Text] [PDF]

				M. A. Purbhoo, Y. Li, D. H. Sutton, J. E. Brewer, E. Gostick, G. Bossi, B. Laugel, R. Moysey, E. Baston, N. Liddy, et al. The HLA A*0201-restricted hTERT540-548 peptide is not detected on tumor cells by a CTL clone or a high-affinity T-cell receptor Mol. Cancer Ther., July 1, 2007; 6(7): 2081 - 2091. [Abstract] [Full Text] [PDF]

				J. Kuball, M. L. Dossett, M. Wolfl, W. Y. Ho, R.-H. Voss, C. Fowler, and P. D. Greenberg Facilitating matched pairing and expression of TCR chains introduced into human T cells Blood, March 15, 2007; 109(6): 2331 - 2338. [Abstract] [Full Text] [PDF]

				M. A. Purbhoo, D. H. Sutton, J. E. Brewer, R. E. Mullings, M. E. Hill, T. M. Mahon, J. Karbach, E. Jager, B. J. Cameron, N. Lissin, et al. Quantifying and Imaging NY-ESO-1/LAGE-1-Derived Epitopes on Tumor Cells Using High Affinity T Cell Receptors. J. Immunol., June 15, 2006; 176(12): 7308 - 7316. [Abstract] [Full Text] [PDF]

				S.A. Richman, S.J. Healan, K.S. Weber, D.L. Donermeyer, M.L. Dossett, P.D. Greenberg, P.M. Allen, and D.M. Kranz Development of a novel strategy for engineering high-affinity proteins by yeast display Protein Eng. Des. Sel., June 1, 2006; 19(6): 255 - 264. [Abstract] [Full Text] [PDF]

				X. Zhu, H. J. Belmont, S. Price-Schiavi, B. Liu, H.-i. Lee, M. Fernandez, R. L. Wong, J. Builes, P. R. Rhode, and H. C. Wong Visualization of p53264-272/HLA-A*0201 Complexes Naturally Presented on Tumor Cell Surface by a Multimeric Soluble Single-Chain T Cell Receptor. J. Immunol., March 1, 2006; 176(5): 3223 - 3232. [Abstract] [Full Text] [PDF]

				L. Wooldridge, H. A. van den Berg, M. Glick, E. Gostick, B. Laugel, S. L. Hutchinson, A. Milicic, J. M. Brenchley, D. C. Douek, D. A. Price, et al. Interaction between the CD8 Coreceptor and Major Histocompatibility Complex Class I Stabilizes T Cell Receptor-Antigen Complexes at the Cell Surface J. Biol. Chem., July 29, 2005; 280(30): 27491 - 27501. [Abstract] [Full Text] [PDF]